Previous Close | 101.15 |
Open | 101.18 |
Bid | 99.15 x 1100 |
Ask | 99.54 x 1000 |
Day's Range | 99.32 - 101.53 |
52 Week Range | 84.68 - 121.28 |
Volume | |
Avg. Volume | 100,414 |
Market Cap | 1.878B |
Beta (5Y Monthly) | 0.53 |
PE Ratio (TTM) | 34.68 |
EPS (TTM) | 2.87 |
Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
Forward Dividend & Yield | 0.56 (0.48%) |
Ex-Dividend Date | Sep 08, 2022 |
1y Target Est | 133.25 |
ICF (NASDAQ:ICFI), a global consulting and technology services provider, will release its fourth quarter and full year 2022 results on Tuesday, February 28, 2023, after the market close.
The National Institutes of Health (NIH) National Cancer Institute (NCI) recently awarded global consulting and technology services provider ICF (NASDAQ:ICFI) a new $161 million task order to provide digital modernization services. The task order, which was the first awarded to the company under the Center for Biomedical Informatics and Information Technology (CBIIT) IT blanket purchase agreement, has a term of five years, including a six-month base and nine six-month options.
ICF (NASDAQ: ICFI), a global consulting and technology services provider, today announced that Mark Lee has been named chief technology executive, and Jennifer Welham will lead ICF's health, human services and workforce business.